Malika Davids

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?

Anil Pooran, Elize Pieterson, Malika Davids et al. · PLoS ONE · 2013 · 232 citations · Full text

Public Health, Infectious Disease Control, Pharmacoeconomics +17

Regulatory T Cells Attenuate Mycobacterial Stasis in Alveolar and Blood-derived Macrophages from Patients with Tuberculosis

Patricia L. Semple, Anke Binder, Malika Davids et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 81 citations

Life Sciences, Immunology, Infectious Diseases +17

Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial

Greg Calligaro, Grant Theron, Hoosain Khalfey et al. · The Lancet Respiratory Medicine · 2015 · 57 citations

Public Health, Clinical Sciences, Internal Medicine +16